肝外胆管がん(Extrahepatic Bile Duct Cancer):世界の治験レビュー(2015年上半期版)

【英語タイトル】Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015

GlobalDataが出版した調査資料(GDHC2584CTIDB)・商品コード:GDHC2584CTIDB
・発行会社(調査会社):GlobalData
・発行日:2015年2月27日
・ページ数:94
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Site License(同一国内共有可)USD5,000 ⇒換算¥560,000見積依頼/購入/質問フォーム
Enterprisewide License(複数国内共有可)USD7,500 ⇒換算¥840,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
当調査レポートでは、世界における肝外胆管がん(Extrahepatic Bile Duct Cancer) 治療の臨床試験動向について調査・分析し、アジア太平洋/欧州/北米/中南米の主要国における治験件数、段階(フェーズ)別の治験件数、進捗状況別の治験件数、治験目標の達成状況、有望な薬剤、治験関連の最新ニュース、代表的な企業・大学・研究機関における治験概要、代表的な治験のプロファイルなどのデータをまとめてお届けいたします。

・イントロダクション
  - 肝外胆管がん(Extrahepatic Bile Duct Cancer)
  - 当レポートの概要
・肝外胆管がん(Extrahepatic Bile Duct Cancer):各地域別治験状況
  - 各国の治験件数及び平均被験者数
   アジア太平洋の主要国における治験件数
   欧州の主要国における治験件数
   北米の主要国における治験件数
   中東・アフリカの主要国における治験件数
   中南米の主要国における治験件数
・G7諸国での治験件数
・G7諸国での治験件数:段階別
・G7諸国での治験件数:進捗状況別
・段階(フェーズ)別の治験件数:進行中の治験(段階別)
・進捗状況別の治験件数
・治験目標の達成状況
・未完了の治験件数
・一定期間に採用された被験者
・スポンサーの種類別治験件数
・有望なスポンサー
・有望な薬剤
・治験のプロファイル
  - 代表的な企業における治験概要
  - 代表的な大学・研究機関における治験概要
・5つの代表的な治験のプロファイル
【レポートの概要】

Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015

Summary

GlobalData’s clinical trial report, “Extrahepatic Bile Duct Cancer Global Clinical Trials Review, H1, 2015″ provides data on the Extrahepatic Bile Duct Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Extrahepatic Bile Duct Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Extrahepatic Bile Duct Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

【レポートの目次】

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Introduction 5
Extrahepatic Bile Duct Cancer 5
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Clinical Trials by G7 Countries: Proportion of Extrahepatic Bile Duct Cancer to Oncology Clinical Trials 12
Clinical Trials by Phase in G7 Countries 13
Clinical Trials in G7 Countries by Trial Status 14
Clinical Trials by Phase 15
In Progress Trials by Phase 16
Clinical Trials by Trial Status 17
Clinical Trials by End Point Status 18
Unaccomplished Trials of Extrahepatic Bile Duct Cancer 19
Subjects Recruited Over a Period of Time 21
Clinical Trials by Sponsor Type 22
Prominent Sponsors 23
Top Companies Participating in Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials 24
Prominent Drugs 25
Clinical Trial Profiles 26
Clinical Trial Overview of Top Companies 26
AstraZeneca PLC 26
Clinical Trial Overview of AstraZeneca PLC 26
PrECOG, LLC. 27
Clinical Trial Overview of PrECOG, LLC. 27
Daiichi Sankyo Company, Limited 28
Clinical Trial Overview of Daiichi Sankyo Company, Limited 28
Clinical Trial Overview of Top Institutes / Government 29
National Cancer Institute 29
Clinical Trial Overview of National Cancer Institute 29
Memorial Sloan Kettering Cancer Center 31
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 31
Massachusetts General Hospital 32
Clinical Trial Overview of Massachusetts General Hospital 32
National Institutes of Health Clinical Center 33
Clinical Trial Overview of National Institutes of Health Clinical Center 33
North Central Cancer Treatment Group 34
Clinical Trial Overview of North Central Cancer Treatment Group 34
University of Chicago 35
Clinical Trial Overview of University of Chicago 35
Mayo Clinic 36
Clinical Trial Overview of Mayo Clinic 36
SWOG 37
Clinical Trial Overview of SWOG 37
Northwestern University 38
Clinical Trial Overview of Northwestern University 38
Samsung Medical Center 39
Clinical Trial Overview of Samsung Medical Center 39
Five Key Clinical Profiles 40
Appendix 91
Abbreviations 91
Definitions 91
Research Methodology 92
Secondary Research 92
About GlobalData 93
Contact Us 93
Disclaimer 93
Source 94

List of Tables
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Region, 2015* 6
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2015* 9
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 10
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, North America, Top Countries, 2015* 11
Proportion of Extrahepatic Bile Duct Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 12
Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Phase, 2015* 15
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 16
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18
Extrahepatic Bile Duct Cancer Therapeutics, Global, Withdrawn Clinical Trials, 2015* 19
Extrahepatic Bile Duct Cancer Therapeutics, Global, Terminated Clinical Trials, 2015* 20
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21
Extrahepatic Bile Duct Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 22
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2015* 26
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by PrECOG, LLC., 2015* 27
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2015* 28
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2015* 29
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 31
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2015* 32
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institutes of Health Clinical Center, 2015* 33
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Central Cancer Treatment Group, 2015* 34
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Chicago, 2015* 35
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2015* 36
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by SWOG, 2015* 37
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Northwestern University, 2015* 38
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Samsung Medical Center, 2015* 39

List of Figures
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Region (%), 2015* 6
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 7
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 8
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2015* 9
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 10
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 11
Proportion of Extrahepatic Bile Duct Cancer to Oncology Clinical Trials, G7 Countries (%), 2015* 12
Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 13
Extrahepatic Bile Duct Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 14
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2015* 15
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 16
Extrahepatic Bile Duct Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2015* 17
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2015* 18
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 21
Extrahepatic Bile Duct Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 22
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 23
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 24
Extrahepatic Bile Duct Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 25
GlobalData Methodology 92

【レポートのキーワード】

肝外胆管がん(Extrahepatic Bile Duct Cancer)、治験、臨床試験、治験、治療薬

★調査レポート[肝外胆管がん(Extrahepatic Bile Duct Cancer):世界の治験レビュー(2015年上半期版)] (コード:GDHC2584CTIDB)販売に関する免責事項を必ずご確認ください。
★調査レポート[肝外胆管がん(Extrahepatic Bile Duct Cancer):世界の治験レビュー(2015年上半期版)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆